0001209191-18-044262.txt : 20180727
0001209191-18-044262.hdr.sgml : 20180727
20180727174527
ACCESSION NUMBER: 0001209191-18-044262
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180725
FILED AS OF DATE: 20180727
DATE AS OF CHANGE: 20180727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Perlin Jonathan B
CENTRAL INDEX KEY: 0001373493
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11239
FILM NUMBER: 18975712
MAIL ADDRESS:
STREET 1: HCA INC.
STREET 2: ONE PARK PLAZA
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HCA Healthcare, Inc.
CENTRAL INDEX KEY: 0000860730
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 273865930
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PARK PLZ
CITY: NASHVILLE
STATE: TN
ZIP: 37203
BUSINESS PHONE: 6153449551
MAIL ADDRESS:
STREET 1: ONE PARK PLAZA
CITY: NASHVILLE
STATE: TN
ZIP: 37203
FORMER COMPANY:
FORMER CONFORMED NAME: HCA Holdings, Inc.
DATE OF NAME CHANGE: 20101126
FORMER COMPANY:
FORMER CONFORMED NAME: HCA INC/TN
DATE OF NAME CHANGE: 20010627
FORMER COMPANY:
FORMER CONFORMED NAME: HCA THE HEALTHCARE CO
DATE OF NAME CHANGE: 20010419
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-25
0
0000860730
HCA Healthcare, Inc.
HCA
0001373493
Perlin Jonathan B
ONE PARK PLAZA
NASHVILLE
TN
37203
0
1
0
0
Pres-Clinical Services & CMO
Common Stock
2018-07-25
4
M
0
10000
22.10
A
105393.6171
D
Common Stock
2018-07-25
4
S
0
10000
112.53
D
95393.6171
D
Common Stock
2018-07-25
4
M
0
150000
22.95
A
245393.6171
D
Common Stock
2018-07-25
4
F
0
76702
118.13
D
168691.6171
D
Common Stock
2018-07-27
4
S
0
32846
122.9176
D
135845.6171
D
Common Stock
2018-07-27
4
S
0
37152
123.5188
D
98693.6171
D
Common Stock
2018-07-27
4
S
0
3300
124.47
D
95393.6171
D
Common Stock
913
I
By 2011 GRAT, Reporting Person Trustee
Common Stock
3846
I
By 2012 GRAT, Reporting Person Trustee
Non-Qualified Stock Option (right to buy)
22.10
2018-07-25
4
M
0
10000
0.00
D
2021-11-02
Common Stock
10000
0
D
Stock Appreciation Right
22.95
2018-07-25
4
M
0
75000
0.00
D
2022-02-08
Common Stock
75000
0
D
Stock Appreciation Right
22.95
2018-07-25
4
M
0
75000
0.00
D
2022-02-08
Common Stock
75000
0
D
The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.28 to $123.27, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.29 to $124.27, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets.
The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.
The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.
/s/ Natalie Harrison Cline, Attorney-in-Fact
2018-07-27
EX-24.4_802975
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR SEC REPORTING OBLIGATIONS
KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes,
constitutes and appoints Robert A. Waterman, John M. Franck II and Natalie
Harrison Cline as the undersigned's true and lawful attorneys-in-fact, with full
power and authority as hereinafter described on behalf of and in the name, place
and stead of the undersigned to:
(1) prepare, execute, acknowledge, deliver and file a Form ID (including any
amendments or authentications thereto) with respect to obtaining EDGAR codes,
with the U.S. Securities and Exchange Commission;
(2) prepare, execute, acknowledge, deliver and file Forms 3, 4 and 5 (including
any amendments thereto) with respect to the securities of HCA Inc., a Delaware
corporation (the "Company"), with the U.S. Securities and Exchange Commission,
any national securities exchanges and the Company, as considered necessary or
advisable under Section 16(a) of the Securities Exchange Act of 1934 and the
rules and regulations promulgated thereunder, as amended from time to time (the
"Exchange Act");
(3) seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information on transactions in the Company's securities
from any third party, including brokers, employee benefit plan administrators
and trustees, and the undersigned hereby authorizes any such person to release
any such information to the undersigned and approves and ratifies any such
release of information; and
(4) perform any and all other acts which in the discretion of such
attorneys-in-fact are necessary or desirable for and on behalf of the
undersigned in connection with the foregoing.
The undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such
attorneys-in-fact to act in their discretion on information provided to such
attorneys-in-fact without independent verification of such information;
(2) any documents prepared and/or executed by such attorneys-in-fact on behalf
of the undersigned pursuant to this Power of Attorney will be in such form and
will contain such information and disclosure as such attorney-in-fact, in his or
her discretion, deems necessary or desirable;
(3) neither the Company nor such attorneys-in-fact assumes (i) any liability
for the undersigned's responsibility to comply with the requirements of the
Exchange Act, (ii) any liability of the undersigned for any failure to comply
with such requirements, or (iii) any obligation or liability of the undersigned
for profit disgorgement under Section 16(b) of the Exchange Act; and
(4) this Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under the Exchange Act,
including without limitation the reporting requirements under Section 16 of the
Exchange Act.
The undersigned hereby gives and grants the foregoing attorneys-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or could
do if present, with full power of substitution and revocation, hereby ratifying
all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, of, for and on behalf of the undersigned, shall lawfully do or
cause to be done by virtue of this Power of Attorney.
This Power of Attorney shall remain in full force and effect until revoked by
the undersigned in a signed writing delivered to such attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 11th day of April, 2008.
/s/Jonathan B. Perlin
Print Name: Jonathan B. Perlin, MD